Allarity Therapeutics (ALLR) Short Interest Ratio & Short Volume $0.22 +0.03 (+15.56%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Allarity Therapeutics Short Interest DataCurrent Short Interest564,200 sharesPrevious Short Interest1,720,000 sharesChange Vs. Previous Month-67.20%Dollar Volume Sold Short$112,275.80Short Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares17,607,000 sharesFloat Size25,590,000 sharesShort Percent of Float2.20%Today's Trading Volume14,161,139 sharesAverage Trading Volume3,860,191 sharesToday's Volume Vs. Average367% Short Selling Allarity Therapeutics ? Sign up to receive the latest short interest report for Allarity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALLR Short Interest Over TimeALLR Days to Cover Over TimeALLR Percentage of Float Shorted Over Time Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. Allarity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024564,200 shares $112,275.80 -67.2%2.2%0.1 $0.20 6/30/20241,720,000 shares $366,188.00 +65.4%6.7%0.3 $0.21 6/15/20241,040,000 shares $473,096.00 -11.1%4.1%0.2 $0.45 5/31/20241,170,000 shares $720,720.00 +149.6%6.7%0.3 $0.62 5/15/2024468,800 shares $318,830.88 +111.9%3.0%0.1 $0.68 4/30/2024221,200 shares $280,924.00 +110.5%10.4%0.1 $1.27 Get the Latest News and Ratings for ALLR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024105,100 shares $210,200.00 +317.1%25.0%0.2 $2.00 3/31/202425,200 shares $151,754.40 -95.9%9.2%0.8 $6.02 3/15/2024614,300 shares $213,162.10 -5.9%11.8%4.7 $0.35 2/29/2024652,700 shares $252,333.82 +1.9%12.5%1.5 $0.39 2/15/2024640,300 shares $260,281.95 +0.8%17.2%0.4 $0.41 1/31/2024635,000 shares $275,971.00 -6.0%N/A0.4 $0.43 1/15/2024675,700 shares $333,322.81 +0.4%N/A0.5 $0.49 12/31/2023673,000 shares $370,890.30 -72.9%N/A0.5 $0.55 12/15/20232,480,000 shares $1.31 million +1,672.7%N/A1.7 $0.53 11/30/2023139,900 shares $77,392.68 -26.3%N/A0.1 $0.55 11/15/2023189,800 shares $93,951.00 -19.2%N/A0.6 $0.50 10/31/2023234,800 shares $130,783.60 -18.5%N/A0.8 $0.56 10/15/2023288,200 shares $208,483.88 +8.9%N/A0.5 $0.72 9/30/2023264,600 shares $197,656.20 -2.9%N/A0.4 $0.75 9/15/2023272,600 shares $258,970.00 +994.8%N/A0.3 $0.95 8/31/202324,900 shares $46,065.00 -15.6%N/A0 $1.85 8/15/202329,500 shares $57,230.00 +118.5%N/A0 $1.94 7/31/202313,500 shares $34,290.00 -78.6%N/A0 $2.54 7/15/202363,000 shares $190,260.00 +176.3%N/A0.2 $3.02 6/30/202322,800 shares $150,480.00 -87.8%N/A0.1 $6.60 6/15/2023186,300 shares $35,601.93 -33.6%N/A0.1 $0.19 5/31/2023280,600 shares $73,938.10 -40.4%N/A0.1 $0.26 5/15/2023470,800 shares $180,316.40 +180.4%N/A0.2 $0.38 4/30/2023167,900 shares $73,876.00 +21.1%N/A0.1 $0.44 4/15/2023138,700 shares $199,728.00 +134.7%N/A0.1 $1.44 3/31/202359,100 shares $99,288.00 -70.0%N/A0.3 $1.68 3/15/2023196,700 shares $894,985.00 -71.6%1.5%0 $4.55 2/28/2023691,700 shares $127,964.50 +23.8%7.5%0.3 $0.19 2/15/2023558,800 shares $105,054.40 -38.7%6.1%0.2 $0.19 1/31/2023911,800 shares $227,950.00 +320.4%9.9%0.4 $0.25 1/15/2023216,900 shares $52,923.60 +38.9%2.4%0.1 $0.24 12/30/2022156,200 shares $45,891.56 +39.2%1.7%0.2 $0.29 12/15/2022112,200 shares $29,733.00 +2,852.6%1.3%0.2 $0.27 11/30/20223,800 shares $1,706.20 -56.3%0.1%0 $0.45We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! 11/15/20228,700 shares $4,352.61 -46.0%0.1%0.1 $0.50 10/31/202216,100 shares $9,017.61 -13.9%0.2%0.1 $0.56 10/15/202218,700 shares $15,427.50 +167.1%0.3%0.1 $0.83 9/30/20227,000 shares $7,700.00 -94.0%0.1%0 $1.10 9/15/2022117,400 shares $147,924.00 +161.5%1.6%0.4 $1.26 8/31/202244,900 shares $52,533.00 +77.5%0.6%0.2 $1.17 8/15/202225,300 shares $28,083.00 -57.4%0.3%0.1 $1.11 7/31/202259,400 shares $71,280.00 +324.3%0.8%0.4 $1.20 7/15/202214,000 shares $16,520.00 No Change0.2%0.1 $1.18 ALLR Short Interest - Frequently Asked Questions What is Allarity Therapeutics' current short interest? Short interest is the volume of Allarity Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 564,200 shares of ALLR short. 2.20% of Allarity Therapeutics' shares are currently sold short. Learn More on Allarity Therapeutics' current short interest. What is a good short interest percentage for Allarity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.20% of Allarity Therapeutics' floating shares are currently sold short. Is Allarity Therapeutics' short interest increasing or decreasing? Allarity Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 564,200 shares, a decline of 67.2% from the previous total of 1,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Allarity Therapeutics' float size? Allarity Therapeutics currently has issued a total of 17,607,000 shares. Some of Allarity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Allarity Therapeutics currently has a public float of 25,590,000 shares. How does Allarity Therapeutics' short interest compare to its competitors? 2.20% of Allarity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Allarity Therapeutics: Vaccinex, Inc. (1.77%), Monopar Therapeutics Inc. (0.67%), Eterna Therapeutics Inc. (1.84%), NeuroSense Therapeutics Ltd. (1.11%), RedHill Biopharma Ltd. (1.07%), NuCana plc (1.71%), Tonix Pharmaceuticals Holding Corp. (2.46%), Pieris Pharmaceuticals, Inc. (0.84%), Agile Therapeutics, Inc. (12.68%), Aeterna Zentaris Inc. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Allarity Therapeutics stock? Short selling ALLR is an investing strategy that aims to generate trading profit from Allarity Therapeutics as its price is falling. ALLR shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allarity Therapeutics? A short squeeze for Allarity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLR, which in turn drives the price of the stock up even further. How often is Allarity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLR, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Vaccinex Short Interest Monopar Therapeutics Short Interest Eterna Therapeutics Short Interest NeuroSense Therapeutics Short Interest RedHill Biopharma Short Interest NuCana Short Interest Tonix Pharmaceuticals Short Interest Pieris Pharmaceuticals Short Interest Agile Therapeutics Short Interest Aeterna Zentaris Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALLR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.